Background and aims No drugs are currently approved for Coronavirus Disease-2019 (COVID-19),
although some have been tried. In view of recent studies and discussion on …

Background and aims High prevalence of diabetes makes it an important comorbidity in
patients with COVID-19. We sought to review and analyze the data regarding the association …

The rapidly increasing number of mobile devices, voluminous data, and higher data rate are
pushing to rethink the current generation of the cellular mobile communication. The next or …

… Kamlesh Khunti professor of primary care diabetes and vascular medicine1, Awadhesh
Kumar Singh senior consultant2, Manish Pareek associate clinical professor in infectious …

Background and aims There are increasing case reports of rhino-orbital mucormycosis in
people with coronavirus disease 2019 (COVID-19), especially from India. Diabetes mellitus (…

COVID-19 (Coronavirus Disease-2019), a disease caused by the coronavirus SARS-CoV-2
(Severe Acute Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading …

Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-obesity
drugs have been approved currently by US FDA. Several phase 3 trials have …

Background and aims Molnupiravir is a newer oral antiviral drug that has recently been
tested in COVID-19. We aim to conduct a systematic review of literature to find out the efficacy …

Background and aims COVID-19 is already a pandemic. Emerging data suggest an increased
association and a heightened mortality in patients of COVID-19 with comorbidities. We …

Background and aims Interest in corticosteroid therapy in COVID-19 has been rekindled
after the results from Randomized Evaluation of COVid-19 thERapY (RECOVERY) Trial. …